Q2 FY2026 · ended Jul 5, 2026 · Revenue $729.69M, +1.3% YoY · Filed Aug 11, 2026
Revvity, Inc (RVTY) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In Q2 of fiscal 2026, the quarter ended Jul 5, 2026, it reported revenue of $729.7 million and net income of $51.8 million. Free cash flow was $180.9 million. As of Jul 5, 2026 it held $1.0 billion in cash and investments and $3.4 billion in total debt.
Revenue
$729.69M
+1.3% vs year-ago quarter
Net income
$51.82M
-3.9% vs year-ago quarter
Operating cash flow
$191.94M
+42.9% vs year-ago quarter
Free cash flow
$180.87M
+56.7% vs year-ago quarter
EPS
$0.47
+2.2% vs year-ago quarter
Dividend per share
$0.07
+0.0% vs year-ago quarter
Shares outstanding
111.59M
-3.9% vs year-ago quarter
Net cash
$-2.34B
Q2 FY2026
Operating margin
12.3%
TTM
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- RVTY (NYSE)
- Fiscal year ends
- December 29
- Incorporated in
- MA
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 31791
- Former names
- PERKINELMER INC (until Apr 14, 2023); EG&G INC (until Jul 26, 1999)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jul 5, 2026 |
Q1 FY2026 Apr 5, 2026 |
Q4 FY2025 Dec 28, 2025 |
Q3 FY2025 Sep 28, 2025 |
Q2 FY2025 Jun 29, 2025 |
|---|---|---|---|---|---|
| Revenue | $729.7M | $711.1M | $772.1M | $698.9M | $720.3M |
| Operating income | $89.3M | $75.9M | $111.7M | $81.9M | $90.8M |
| Net income | $51.8M | $40.7M | $98.4M | $46.7M | $53.9M |
| Diluted EPS | $0.47 | $0.36 | $0.87 | $0.40 | $0.46 |
| Operating cash flow | $191.9M | $115.2M | $182.0M | $138.5M | $134.3M |
| Free cash flow | $180.9M | $95.5M | $161.8M | $120.0M | $115.5M |
| Total assets | $12.0B | $12.0B | $12.2B | $12.1B | $12.4B |
| Total liabilities | $4.8B | $4.8B | $4.9B | $4.8B | $4.8B |
| Stockholders' equity | $7.2B | $7.2B | $7.3B | $7.4B | $7.6B |
| Cash and investments | $1.0B | $860.3M | $947.8M | $931.4M | $991.8M |
| Total debt | $3.4B | $3.4B | $3.4B | $3.4B | $3.4B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Other events
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jul 5, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 4, 2026 | Aug 4, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Apr 5, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 5, 2026 | May 5, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 1, 2026 | Apr 28, 2026 |
All 1000 Revvity, Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.